Up to 25% of patients with profound neutropenia lasting for> 10 days develop lung infiltrates,
which frequently do not respond to broad-spectrum antibacterial therapy. While a causative …

Background Invasive fungal diseases remain a major cause of morbidity and mortality in
cancer patients undergoing intensive cytotoxic therapy. The choice of the most appropriate …

Over the past few decades advancements in hematologic malignancies (HMs) and in
hematopoietic cell transplantation (HCT) have expanded treatment options and prolonged …

Invasive fungal infections (IFI) remain life-threatening complications in haematological
patients. The aim of the study was to present the experience of a single centre in the surgical …

OBJECTIVES Pulmonary invasive fungal infections (IFIs) are associated with high mortality
in patients being treated for haematological malignancy. There is limited understanding of …

We investigated the incidence, pathogens and risk factors of invasive pulmonary fungal
infection (IPFI) in patients with hematological malignancies who did not receive …

Delayed and incorrect diagnoses are potential risk factors leading to high mortality of
invasive aspergillosis (IA). Matrix-assisted laser desorption/ionization time-of-flight mass …

Background Invasive fungal disease (IFD) is typically aggressive and related with high
mortality in children with a hematological malignancy. The association of medical and …

Neosartorya udagawae is a known cause of fungal infection in humans and animals. It is
found to be more refractory to antifungal treatment in comparison to other Aspergillus …

Objective Although invasive fungal disease (IFD) is an important complication in allogeneic
hematopoietic stem cell transplantation (HSCT), the clinical significance of surgery …